- Home
- ADRX vs SRCE Comparison
ADRX vs SRCE Comparison
Compare ADRX & SRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ADRX | SRCE |
|---|---|---|
| Founded | 2019 | 1863 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 2.2B |
| IPO Year | 2026 | 1995 |
Fundamental Metrics
Financial Performance| Metric | ADRX | SRCE |
|---|---|---|
| Price | $14.58 | $88.13 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 3 |
| Target Price | $34.25 | ★ $95.00 |
| AVG Volume (30 Days) | ★ 396.7K | 90.1K |
| Earning Date | 11-12-2026 | 10-22-2026 |
| Dividend Yield | N/A | ★ 1.95% |
| EPS Growth | N/A | ★ 19.59 |
| EPS | N/A | ★ 5.62 |
| Revenue | N/A | N/A |
| Revenue This Year | $89.41 | $9.20 |
| Revenue Next Year | $510.33 | $3.21 |
| P/E Ratio | ★ N/A | $15.69 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.50 | $59.55 |
| 52 Week High | $19.57 | $91.46 |
Technical Indicators
Market Signals| Indicator | ADRX | SRCE |
|---|---|---|
| Relative Strength Index (RSI) | 39.02 | 55.08 |
| Support Level | $12.50 | $85.79 |
| Resistance Level | $18.94 | $90.86 |
| Average True Range (ATR) | 1.59 | 1.64 |
| MACD | -0.16 | -0.02 |
| Stochastic Oscillator | 30.24 | 39.02 |
Price Performance
Historical ComparisonAbout ADRX ADARx Pharmaceuticals Inc. Common Stock
Adarx Pharmaceuticals Inc is a late-clinical stage biotechnology company focused on developing next-generation siRNA therapeutics designed to treat a broad spectrum of diseases. Its pipeline includes three clinical-stage programs and two advanced preclinical programs. The three hepatic-targeted programs are agazisiran, onvuzosiran, and ADX-626, while the two extrahepatic-targeted programs are ADX-077 and ADX-199.
About SRCE 1st Source Corporation
1st Source Corp provides specialized financing services for construction equipment, aircraft, and vehicle types through its Specialty Finance activities. The company offers commercial, small business, agricultural, and real estate loans, along with commercial leasing, treasury management, and payment services, including Fedwires, ACH, and merchant services. It also provides Renewable Energy Financing for commercial solar projects, a full range of consumer banking products, Trust and Wealth Advisory Services, and insurance products. The company operates in the commercial banking segment, which provides commercial and consumer banking services, trust and wealth advisory services, and insurance to individual and business clients across its markets.